Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Standalone methacrylated extracellular matrix for digital light processing bioprinting: a practical workflow.

Frontiers in bioengineering and biotechnology·2026
Same author

3D Printing of Oxygen-Sensing ECM-Based Skin Graft for Personalized Treatment of Chronic Wounds-A Technological Proof of Concept.

Journal of functional biomaterials·2026
Same author

Rat Islet pECM Hydrogel-Based Microencapsulation: A Protective Niche for Xenotransplantation.

Gels (Basel, Switzerland)·2025
Same author

Solubilized Pancreatic Extracellular Matrix from Juvenile Pigs Protects Isolated Human Islets from Hypoxia-Induced Damage: A Viable Option for Clinical Islet Transplantation.

Journal of tissue engineering and regenerative medicine·2025
Same author

Towards catalytic fluoroquinolones: from metal-catalyzed to metal-free DNA cleavage.

RSC medicinal chemistry·2025
Same author

Porcine Bone Extracellular Matrix Hydrogel as a Promising Graft for Bone Regeneration.

Gels (Basel, Switzerland)·2025

Related Experiment Video

Updated: Jun 2, 2026

Simultaneous Electrical and Mechanical Stimulation to Enhance Cells' Cardiomyogenic Potential
07:41

Simultaneous Electrical and Mechanical Stimulation to Enhance Cells' Cardiomyogenic Potential

Published on: January 18, 2019

Engineering cell platforms for myocardial regeneration.

Udi Sarig1, Marcelle Machluf

  • 1Technion-Israel Institute of Technology, The Laboratory of Cancer, Drug Delivery & Mammalian Cell Technology, Faculty of Biotechnology & Food Engineering, Haifa 32000, Israel.

Expert Opinion on Biological Therapy
|May 6, 2011
PubMed
Summary

Engineered cell-platforms show promise for heart repair after myocardial infarction (MI). Combined cell-biomaterial therapies are superior, but clinical translation requires overcoming challenges in cell survival and scaffold design.

More Related Videos

Generation of Aligned Functional Myocardial Tissue Through Microcontact Printing
11:09

Generation of Aligned Functional Myocardial Tissue Through Microcontact Printing

Published on: March 19, 2013

Pluripotent Stem Cell Derived Cardiac Cells for Myocardial Repair
06:37

Pluripotent Stem Cell Derived Cardiac Cells for Myocardial Repair

Published on: February 3, 2017

Related Experiment Videos

Last Updated: Jun 2, 2026

Simultaneous Electrical and Mechanical Stimulation to Enhance Cells' Cardiomyogenic Potential
07:41

Simultaneous Electrical and Mechanical Stimulation to Enhance Cells' Cardiomyogenic Potential

Published on: January 18, 2019

Generation of Aligned Functional Myocardial Tissue Through Microcontact Printing
11:09

Generation of Aligned Functional Myocardial Tissue Through Microcontact Printing

Published on: March 19, 2013

Pluripotent Stem Cell Derived Cardiac Cells for Myocardial Repair
06:37

Pluripotent Stem Cell Derived Cardiac Cells for Myocardial Repair

Published on: February 3, 2017

Area of Science:

  • Regenerative Medicine
  • Biomaterials Science
  • Cardiovascular Research

Background:

  • Engineered cell-platforms are investigated for treating myocardial infarction (MI) and heart failure.
  • These platforms utilize cells and/or biomaterial scaffolds for cardiac tissue regeneration.

Purpose of the Study:

  • To review advancements in cell-platforms for myocardial regeneration.
  • To compare injectable and patch-based cell platforms, including cell-only and cell-scaffold therapies.
  • To identify current limitations and future directions for clinical translation.

Main Methods:

  • Categorization of cell-platforms into injectable and patch-based approaches.
  • Summary of in-vivo successes and clinical feasibility of various cell-platform strategies.
  • Comparison of natural and synthetic scaffolds with cell-based therapy alone.

Main Results:

  • Combined cell-biomaterial scaffold therapy demonstrates superiority over cell therapy alone.
  • Pre-clinical successes are hindered by limited cell survival, construct thickness, and 2D culture methods.
  • Cardiac and induced pluripotent stem cells are identified as key future research areas.

Conclusions:

  • Dynamic 3D cultivation platforms are crucial for improving outcomes and enabling rapid screening.
  • Addressing challenges in cell survival and scaffold engineering is vital for clinical application.
  • Future research should focus on advanced 3D culture systems and stem cell therapies for enhanced myocardial regeneration.